⌘K

Login Start Free

Home/Filings/4/0001179110-13-006723

4//SEC Filing

GRILLO LOPEZ ANTONIO J 4

Accession 0001179110-13-006723

CIK 0001012140other

View on SEC.gov Company Profile

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 9:47 PM ET

Size

26.4 KB

Accession

0001179110-13-006723

Insider Transaction Report

Form 4

Period: 2013-04-11

ONYX PHARMACEUTICALS INCONXX

GRILLO LOPEZ ANTONIO J

Director

Transactions

Exercise/Conversion
Common Stock
2013-04-11$31.72/sh+10,000$317,200→ 36,600 total
Exercise/Conversion
Stock Option (Right to Buy)
2013-04-11−3,164→ 0 total
Exercise: $28.55Exp: 2019-03-31→ Common Stock (3,164 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2013-04-11−10,000→ 0 total
Exercise: $31.72Exp: 2017-08-13→ Common Stock (10,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2013-04-11−5,000→ 0 total
Exercise: $35.18Exp: 2021-03-31→ Common Stock (5,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2013-04-11−5,000→ 0 total
Exercise: $30.28Exp: 2020-03-31→ Common Stock (5,000 underlying)
Exercise/Conversion
Common Stock
2013-04-11$30.28/sh+5,000$151,400→ 19,764 total
Exercise/Conversion
Common Stock
2013-04-11$12.87/sh+10,000$128,700→ 16,600 total
Exercise/Conversion
Common Stock
2013-04-11$28.55/sh+3,164$90,332→ 9,764 total
Exercise/Conversion
Common Stock
2013-04-11$35.18/sh+5,000$175,900→ 14,764 total
Exercise/Conversion
Common Stock
2013-04-11$39.84/sh+10,000$398,400→ 26,600 total
Sale
Common Stock
2013-04-11$98.77/sh−13,164$1,300,208→ 6,600 total
Sale
Common Stock
2013-04-11$95.83/sh−30,000$2,874,906→ 6,600 total
Exercise/Conversion
Stock Option (Right to Buy)
2013-04-11−10,000→ 0 total
Exercise: $12.87Exp: 2016-08-14→ Common Stock (10,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2013-04-11−10,000→ 0 total
Exercise: $39.84Exp: 2018-08-12→ Common Stock (10,000 underlying)

Footnotes (3)

[F1]Shares sold pursuant to 10b5-1 plan.
[F2]The shares were sold at prices ranging from $95.83 to $96.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F3]Fully vested.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

ONYX PHARMACEUTICALS INC

CIK 0001012140

Entity typeother

Related Parties

1

filerCIK 0001235942

Filing Metadata

Form type: 4
Filed: Apr 10, 8:00 PM ET
Accepted: Apr 11, 9:47 PM ET
Size: 26.4 KB

View on SEC.gov